Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells.
N-Glycolylneuraminic acid (Neu5Gc) is a widely expressed sialic acid in mammalian cells. Although humans are genetically deficient in producing Neu5Gc, small amounts are present in human cells in vivo. A dietary origin was suggested by human volunteer studies and by observing that free Neu5Gc is metabolically incorporated into cultured human carcinoma cells by unknown mechanisms. We now show that free Neu5Gc uptake also occurs in other human and mammalian cells. Inhibitors of certain non-clathrin-mediated endocytic pathways reduce Neu5Gc accumulation. Studies with human mutant cells show that the lysosomal sialic acid transporter is required for metabolic incorporation of free Neu5Gc. Incorporation of glycosidically bound Neu5Gc from exogenous glycoconjugates (relevant to human gut epithelial exposure to dietary Neu5Gc) requires the transporter as well as the lysosomal sialidase, which presumably acts to release free Neu5Gc. Thus, exogenous Neu5Gc reaches lysosomes via pinocytic/endocytic pathways and is exported in free form into the cytosol, becoming available for activation and transfer to glycoconjugates. In contrast, N-glycolylmannosamine (ManNGc) apparently traverses the plasma membrane by passive diffusion and becomes available for conversion to Neu5Gc in the cytosol. This mechanism can also explain the metabolic incorporation of chemically synthesized unnatural sialic acids, as reported by others. Finally, to our knowledge, this is the first example of delivery to the cytosol of an extracellular small molecule that cannot cross the plasma membrane, utilizing fluid pinocytosis and a specific lysosomal transporter. The approach could, thus, potentially be generalized to any small molecule that has a specific lysosomal transporter but not a plasma membrane transporter.
Bardor
Muriel
M
Glycobiology Research and Training Center, Department of Medicine, University of California San Diego, La Jolla, California, 92093-0687, USA.
Nguyen
Dzung H
DH
Diaz
Sandra
S
Varki
Ajit
A
D000588:Amines / Q000737:chemistry; D000818:Animals; D001692:Biological Transport; D015153:Blotting, Western; D016466:CHO Cells; D018938:Caco-2 Cells; D002460:Cell Line; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D006224:Cricetinae; D003600:Cytosol / Q000378:metabolism; D004058:Diffusion; D004705:Endocytosis; D005347:Fibroblasts / Q000378:metabolism; D005434:Flow Cytometry; D006001:Glycoconjugates / Q000737:chemistry; D006801:Humans; D008247:Lysosomes / Q000201:enzymology / Q000378:metabolism; D013058:Mass Spectrometry; D008856:Microscopy, Fluorescence; D008954:Models, Biological; D009154:Mutation; D009438:Neuraminic Acids / Q000378:metabolism*; D009439:Neuraminidase / Q000378:metabolism; D002679:Pan troglodytes; D011485:Protein Binding; D012794:Sialic Acids / Q000378:metabolism*; D013997:Time Factors
D000588:Amines; D006001:Glycoconjugates; D009438:Neuraminic Acids; D012794:Sialic Acids; C032592:N-glycolylneuraminic acid; D009439:Neuraminidase